Hepatitis C Treatment Alternatives - The National Institutes of Health (NIH) Consensus Development Program

The National Institutes of Health (NIH) Consensus Development Program
The incidence of hepatitis C infection appears to be declining since its peak in 1989. Currently, approximately 30,000 acute new infections are estimated to occur each year, about 25-30

Hepatitis C: The Test
Hepatitis C infection is the most common cause of chronic liver disease in North America; about 2% of all adults in the United States have been exposed to the virus, and 75-85% of those are

Hepatitis C: New Treatment Helps Some, but Cure Remains Elusive
Presently, there is no vaccine or other means of preventing hepatitis C infection. HCV exists in many different forms, called genotypes, confounding researchers in their quest to develop a vaccine

HIV and Hepatitis C
Read what Dr Mark Nelson of London's Chelsea and Westminster Hospital had to say about the increase in Hepatitis C infection in patients at his clinic click here

reatment of chronic hepatitis C virus infection with
To assess the safety and efficacy of consensus interferon (IFN-Con-1), 55 patients with chronic hepatitis C infection were treated with either 3, 6, 9, 12, or 15 microg IFN-Con-1 s